0001209191-23-037372.txt : 20230615
0001209191-23-037372.hdr.sgml : 20230615
20230615164052
ACCESSION NUMBER: 0001209191-23-037372
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230614
FILED AS OF DATE: 20230615
DATE AS OF CHANGE: 20230615
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Coulie Bernard
CENTRAL INDEX KEY: 0001808895
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39662
FILM NUMBER: 231017979
MAIL ADDRESS:
STREET 1: C/O PLIANT THERAPEUTICS, INC.
STREET 2: 260 LITTLEFIELD AVENUE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SQZ Biotechnologies Co
CENTRAL INDEX KEY: 0001604477
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 462431115
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 200 ARSENAL YARDS BLVD., STE. 210
CITY: WATERTOWN
STATE: MA
ZIP: 02472
BUSINESS PHONE: 617-898-8824
MAIL ADDRESS:
STREET 1: 200 ARSENAL YARDS BLVD., STE. 210
CITY: WATERTOWN
STATE: MA
ZIP: 02472
4
1
doc4.xml
FORM 4 SUBMISSION
X0407
4
2023-06-14
0
0001604477
SQZ Biotechnologies Co
SQZ
0001808895
Coulie Bernard
200 ARSENAL YARDS BLVD, SUITE 210
WATERTOWN
MA
02472
1
0
0
0
0
Stock Option
0.539
2023-06-14
4
A
0
39875
0.00
A
2033-06-13
Common Stock
39875
39875
D
The option vests and become exercisable on the earlier of (i) June 14, 2024 or (ii) the day immediately prior to the date of the next annual meeting of stockholders following the date of grant, in each case subject to the recipient's continued service on the Board at such time.
/s/ Lawrence Knopf as Attorney in Fact for Bernard Coulie
2023-06-15